Results 71 to 80 of about 395,319 (225)

The Role of Pleural Fluid Tumor Marker Examination in Diagnosing Malignant Pleural Effusion Caused by Primary Lung Cancer

open access: yesJurnal Penyakit Dalam Indonesia
Introduction. Pleural effusion is a frequently acquired lung disorder and based on the type of cause it is divided into malignant and non-malignant pleural effusion.
Cleopas Martin Rumende   +5 more
doaj   +1 more source

Soluble CD40 in plasma and malignant pleural effusion with non-small cell lung cancer: A potential marker of prognosis

open access: yesChronic Diseases and Translational Medicine, 2015
Objective: Soluble CD40 (sCD40) is a potential modulator for both antitumor responses and CD40-based immunotherapy; however the levels and significance of sCD40 in non-small cell lung cancer (NSCLC) patients with malignant pleural effusion are unknown ...
Chuan-Yong Mu   +4 more
doaj   +1 more source

mRNA markers associated with malignant pleural effusion

open access: yes, 2023
[[abstract]]Malignant pleural effusions (MPE) commonly result from malignant tumors and represent advanced-stage cancers. Thus, in clinical practice, early recognition of MPE is valuable.
Hsu, SC;Chang, SY;Hwang, YT;Terng, HJ;Tsai, CL;Shen, CH;Huang, SK;Chian, CF
core   +1 more source

Human biomarker navigator

open access: yesiMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

The investigation of the volatile metabolites of lung cancer from the microenvironment of malignant pleural effusion

open access: yesScientific Reports, 2021
For malignant pleural effusions, pleural fluid cytology is a diagnostic method, but sensitivity is low. The pleural fluid contains metabolites directly released from cancer cells.
Ke-Cheng Chen   +4 more
doaj   +1 more source

Thoracoscopic techniques in the diagnosis and surgical treatment of pleural effusions—advantages and disadvantages of different thoracoscopic approaches [PDF]

open access: yes
Introduction: Pleural effusions are among the most commonly encountered conditions in the field of thoracic surgery. There are numerous diagnostic and treatment options, but the timing and precise choice of intervention remains critical.Aim: The aim of ...
Marinova, Katerina; Medical University of Varna
core   +2 more sources

Microbiome profile associated with malignant pleural effusion [PDF]

open access: yes, 2020
Introduction There is ongoing research into the development of novel molecular markers that may complement fluid cytology malignant pleural effusion (MPE) diagnosis.
Gottel, Neil   +11 more
core   +1 more source

Determinants of Early Renal Function Recovery After TIPS in Patients With Portal Hypertension

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Renal dysfunction frequently occurs in patients with portal hypertension and is linked to unfavorable clinical outcomes. Transjugular intrahepatic portosystemic shunt (TIPS) has the potential to enhance renal perfusion through portal decompression; however, factors predicting early improvement in renal function remain insufficiently defined ...
Meng Jia   +6 more
wiley   +1 more source

Mediastinal undifferentiated pleomorphic sarcoma with pleural effusion cytopathologically misdiagnosed as epithelial malignant pleural mesothelioma: An autopsy case report

open access: yesThoracic Cancer, 2021
Undifferentiated pleomorphic sarcoma (UPS) is a new disease in the World Health Organization's classification of tumors of soft tissue and bone published in 2013. Primary mediastinal UPS is rare, especially with pleural effusion.
Kinnosuke Matsumoto   +7 more
doaj   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy